Editorial: Transfusion Alternatives in Transfusion Medicine 1999–2012

K. Messmer
{"title":"Editorial: Transfusion Alternatives in Transfusion Medicine 1999–2012","authors":"K. Messmer","doi":"10.1111/J.1778-428X.2012.01176.X","DOIUrl":null,"url":null,"abstract":"Transfusion Alternatives in Transfusion Medicine (TATM) was launched in 1999 shortly after the Network for the Advancement of Transfusion Alternatives (NATA) was created by Professor Jean-Francois Baron (Paris, France), who served both as NATA chair and as TATM editor-inchief. At that time, clinicians and scientists had realized that the risks associated with the administration of blood components and blood-derived products were too high to be accepted by doctors and patients. Efforts were made to avoid allogeneic blood transfusions by establishing alternative methods such as preoperative autologous blood donation, normovolemic hemodilution and cell salvage autotransfusion. The annual symposia organized by NATA were a unique platform to present and discuss the various forms of alternatives to allogeneic blood transfusions in order to evaluate their potential benefits and risks. At each meeting, the actual state of artificial blood, more precisely fluorocarbons and hemoglobinbased solutions, was presented to a multidisciplinary audience. TATM was then published by LM Sante (now Med Ed Global Solutions), the agency also in charge of organizing NATA symposia. In 2002, when Professor Baron retired from his positions of NATA chair and TATM editor-in-chief, I was assigned by the NATA board of directors to take over both positions. At the end of my 3-year term, Professor Maniatis was elected as NATA chair and I was invited to continue as TATM editor-in-chief. At that time, the NATA board decided to look for a professional publisher for the journal and entrusted Wiley-Blackwell (Oxford, UK) with the publication of the journal. The publisher put high energy and efforts in relaunching TATM; however, the potential authors of articles dealing with transfusion medicine and alternatives remained reluctant to send their original papers to TATM as it was not indexed in the main medical databases, which in turn made it difficult to maintain a regular publication schedule, one of the key requirements for indexing. Although TATM was able to publish excellent review articles by leading experts on specific topics, as well as several outstanding themed issues coordinated by renowned guest editors, the board of directors finally came to the conclusion that the efforts required to maintain the journal may be more fruitfully dedicated to developing the NATA website (http://www.nataonline. com) and a continuing medical education e-learning program, while developing partnerships with indexed journals in the field of transfusion medicine. As editor-in-chief, I would like to express my sincere gratitude to the NATA board of directors for entrusting me the official journal of NATA for the last decade. Today I would like to thank all the colleagues who submitted manuscripts to TATM, the associate editors, editorial board members, reviewers and guest editors who helped the journal stick to high quality standards, and the team at Wiley-Blackwell, particularly Sam Gough and Valerie Oliveiro who in recent years provided us with a highly professional support. The greatest support over the years, however, came from Francois Christory, who has served as Managing Editor of TATM since 2001. Without his help and enthusiasm for the goals of NATA and TATM, namely to reduce or avoid the risks associated with the administration of allogeneic blood and blood-derived products, TATM would not have served the medical community successfully for so many years. Transfusion Alternatives in Transfusion Medicine TATM","PeriodicalId":90375,"journal":{"name":"Transfusion alternatives in transfusion medicine : TATM","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2012-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/J.1778-428X.2012.01176.X","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transfusion alternatives in transfusion medicine : TATM","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/J.1778-428X.2012.01176.X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Transfusion Alternatives in Transfusion Medicine (TATM) was launched in 1999 shortly after the Network for the Advancement of Transfusion Alternatives (NATA) was created by Professor Jean-Francois Baron (Paris, France), who served both as NATA chair and as TATM editor-inchief. At that time, clinicians and scientists had realized that the risks associated with the administration of blood components and blood-derived products were too high to be accepted by doctors and patients. Efforts were made to avoid allogeneic blood transfusions by establishing alternative methods such as preoperative autologous blood donation, normovolemic hemodilution and cell salvage autotransfusion. The annual symposia organized by NATA were a unique platform to present and discuss the various forms of alternatives to allogeneic blood transfusions in order to evaluate their potential benefits and risks. At each meeting, the actual state of artificial blood, more precisely fluorocarbons and hemoglobinbased solutions, was presented to a multidisciplinary audience. TATM was then published by LM Sante (now Med Ed Global Solutions), the agency also in charge of organizing NATA symposia. In 2002, when Professor Baron retired from his positions of NATA chair and TATM editor-in-chief, I was assigned by the NATA board of directors to take over both positions. At the end of my 3-year term, Professor Maniatis was elected as NATA chair and I was invited to continue as TATM editor-in-chief. At that time, the NATA board decided to look for a professional publisher for the journal and entrusted Wiley-Blackwell (Oxford, UK) with the publication of the journal. The publisher put high energy and efforts in relaunching TATM; however, the potential authors of articles dealing with transfusion medicine and alternatives remained reluctant to send their original papers to TATM as it was not indexed in the main medical databases, which in turn made it difficult to maintain a regular publication schedule, one of the key requirements for indexing. Although TATM was able to publish excellent review articles by leading experts on specific topics, as well as several outstanding themed issues coordinated by renowned guest editors, the board of directors finally came to the conclusion that the efforts required to maintain the journal may be more fruitfully dedicated to developing the NATA website (http://www.nataonline. com) and a continuing medical education e-learning program, while developing partnerships with indexed journals in the field of transfusion medicine. As editor-in-chief, I would like to express my sincere gratitude to the NATA board of directors for entrusting me the official journal of NATA for the last decade. Today I would like to thank all the colleagues who submitted manuscripts to TATM, the associate editors, editorial board members, reviewers and guest editors who helped the journal stick to high quality standards, and the team at Wiley-Blackwell, particularly Sam Gough and Valerie Oliveiro who in recent years provided us with a highly professional support. The greatest support over the years, however, came from Francois Christory, who has served as Managing Editor of TATM since 2001. Without his help and enthusiasm for the goals of NATA and TATM, namely to reduce or avoid the risks associated with the administration of allogeneic blood and blood-derived products, TATM would not have served the medical community successfully for so many years. Transfusion Alternatives in Transfusion Medicine TATM
社论:1999-2012年输血医学中的输血替代方案
输血医学中的输血替代方案(TATM)是在输血替代方案促进网络(NATA)由Jean-Francois Baron教授(法国巴黎)创建后不久于1999年启动的,他曾担任NATA主席和TATM主编。当时,临床医生和科学家已经意识到,与血液成分和血液制品管理相关的风险太高,无法被医生和患者接受。通过建立术前自体献血、等容血液稀释和细胞挽救性自体输血等替代方法,努力避免异体输血。NATA组织的年度专题讨论会是一个独特的平台,介绍和讨论各种形式的同种异体输血替代方案,以评估其潜在的益处和风险。在每次会议上,向多学科听众介绍了人造血液的实际状况,更确切地说,是基于氟碳化合物和血红蛋白的解决方案。TATM随后由LM Sante(现在的Med Ed Global Solutions)出版,该机构还负责组织NATA专题讨论会。2002年,当Baron教授从NATA主席和TATM总编辑的职位上退休时,我被NATA董事会指派接替这两个职位。在我3年的任期结束时,Maniatis教授被选为NATA主席,我被邀请继续担任TATM总编辑。当时,NATA董事会决定为该期刊寻找专业出版商,并委托Wiley-Blackwell (Oxford, UK)出版该期刊。出版商为重新发行《TATM》付出了巨大的精力和努力;然而,涉及输血医学和替代方法的文章的潜在作者仍然不愿意将其原始论文发送给TATM,因为它没有在主要医学数据库中编入索引,这反过来又使其难以维持定期出版时间表,而这是索引的关键要求之一。尽管《TATM》能够发表由知名专家就特定主题撰写的优秀评论文章,以及由知名客座编辑协调的若干杰出主题问题,但董事会最终得出的结论是,维持期刊所需的努力可能更有效地用于开发NATA网站(http://www.nataonline)。Com)和继续医学教育电子学习计划,同时与输血医学领域的索引期刊发展伙伴关系。作为总编辑,我衷心感谢NATA董事会在过去十年中委托我担任NATA官方期刊。今天,我要感谢所有向《TATM》投稿的同事,感谢帮助《TATM》坚持高质量标准的副编辑、编委会成员、审稿人和客座编辑,感谢Wiley-Blackwell的团队,特别是Sam Gough和Valerie Oliveiro,他们近年来为我们提供了高度专业的支持。然而,这些年来最大的支持来自弗朗索瓦·克里斯托里,他自2001年以来一直担任《TATM》的总编辑。如果没有他的帮助和对NATA和TATM目标的热情,即减少或避免与异体血液和血液制品管理相关的风险,TATM不可能成功地为医学界服务这么多年。输血医学中的输血选择
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信